FDA Panel Backs New 'Morning After' Pill06/18/10
THURSDAY, June 17 (HealthDay News) -- A U.S. Food and Drug
Administration advisory panel voted unanimously on Thursday to
recommend approval of a new emergency contraception pill that is
effective for a longer period of time than the "morning after" pill
known as Plan B.
The new drug, ulipristal acetate or UPA, is marketed under the
brand name ellaOne and would be available only by prescription; it
would be effective if taken up to five days after unprotected
intercourse. Plan B, another emergency contraceptive, is only
effective for up to three days after unprotected sex.
Although the FDA does not always follow the recommendations of
its advisory panels, it typically does.
UPA, which is already marketed in 22 European countries, is made
by French pharmaceutical company HRA Pharma.
The drug works by inhibiting ovulation, explained Dr. Paul Fine,
medical director of Planned Parenthood of Houston & Southeast
Texas & Louisiana and a professor of obstetrics, gynecology and
urology at Baylor College of Medicine in Houston.
Fine was author of a study published earlier this year in
The Lancet that found that UPA cut the risk of an unintended
pregnancy in half as compared with levonorgestrel (also known as
Plan B, which is now available over-the-counter) in women who took
it within five days of unprotected sex.
The possibility of the FDA giving a green light to ellaOne has
sparked intense debate as to whether the pill simply prevents
pregnancy or actually induces an abortion.
"It is not an abortion pill," said Fine. "The reason for this is that if ovulation has already occurred and fertilization has occurred, then the pregnancy is going to happen. That is also true with Plan B."
"All we can hope is that the FDA advisory committee will listen to the science that's presented, and the science is very compelling that this is a very safe and very effective drug for emergency contraception," he added.
But anti-abortion advocates disagree.
According to Dr. Joe DeCook, a spokesman for the American
Association of Pro-Life Obstetricians and Gynecologists (AAPLOG),
at the doses recommended, ulipristal will not suppress ovulation
but will, rather, "block the lining of the uterus from receiving
progesterone, which makes it dysfunctional. It will not then
"Life starts when the egg is fertilized. You have a complete genetic human being in a progressive growth stage just like you or me, just smaller than us and less developed," he added. "Ulipristal purposely causes the death of a complete human being, albeit very small and very early. We don't believe it is correct to purposely kill an innocent unborn child, no matter how small."
AAPLOG also has objections on safety grounds, the track record
of studies conducted on the pill and, especially, the fact that
there is a lack of data on the use of minors using the drug.
An FDA report issued earlier this week found UPA to be safe with
no untoward side effects, reported
Agence France-Presse(AFP). The FDA's review found the most
common side effects to be nausea, headache, uterine pain, abdominal
pain, fatigue and dizziness,
Other more serious side effects did not seem to be due to the
drug, the FDA stated.
At lower doses, UPA is being tested in late clinical trials as a
treatment for uterine fibroids, according to Planned
For more on contraception, visit the
U.S. National Library of Medicine.
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.